Summary: In the context of diagnostic procedures for congenital hyperammonaemias a method is described for the detefmination of N-acetylglutamate synthetase in human liver tissue homogenates. The method uses [ 14 C-U]glutamate and acetyl CoA äs Substrates. The reaction product, N-acetylglutamate is separated from the Substrate L-glutamate by chromatography on Extrelut . In a subsequent step on ITLC-SG ready plates N-acetylglutamate is separated from other labeled metabolites such äs Krebs cycle intermediates. The recovery of N-acetylglutamate was 97.8%.
Introduction
arginine was first shown in rat and mice liver mitoCongenital deficiencies have been described for every chondria ** Shigesada & Tatlbana (7 ' 8) ' enzymatic step in the urea cycle (1^3).
Since no gtudie$ Qn human liver hav(? been re p Or ted An enzyme which is not directly involved in the ureä so fär, the enzyme was purified and characterized (9) . qycle,, but plays a key role in its regulatiori, is N-acetylv glütamate synthetase (EC 2.3.
1.1). It is activated by
We recently had the opportunity to observe the first arginine and catalyses the synthesis of N-acetylglutapatient with N-acetylglutamate synthetase deficiency mate, a physiological, potent activator of cärbamyl- (10) . To confirm the diagnosis N-acetylglutamate Phosphate synthetase (4, 5) . It is present in mitochondria synthetase was determined in a liver biopsy specimen. of liver and small intestine (6).
The method presented here allows the determination of the enzyme in liver homogenate corresponding to The synthesis of N-acetylglutamate in mammals äs well about 30 mg o f tissue. It is based on the animal experias the activation of N-acetylglutamate synthetase by mmt ofShigesada & Tatibana (7, 8, 11 
L-arginine (8 mmol/l)
16.9 mg I-arginine HCI are dissolved in 10 ml Tris^EDTA -buffer. 
Materials and Methods

Chemicals
Solventsfor chromatography
A: Methanol (30 ml/l) and formic acid (12 ml/l) in Chloroform, B: Tert. amyl alcohol (300 ml/l) in Chloroform, C: Ether (366 ml/l) and formic acid (24 ml/l) in petroleum et her.
Bromphenol blue 400 mg bromphenol blue are dissolved in a mixture of 2 ml ethanol and 2 ml H 2 O. The pH is adjusted with 0.1 mol/1 NaOH to 6.5-7. The solution is made up to 500 ml with ethanol 960 ml/l. Centrifuge the tubes at 50 000 g for 10 min. l ml of supernatant is appüed on an Extrelut® column (0.55 g Extrelut®/column, 20 cm X l cm <jt). The column is eluted with 50 ml tert. amyl alcohol (300 ml/l) in Chloroform (solvent B). The whple eluate is then eväpöirated under nitrogen in a waterbath (50 °C). The residue is diluted in 100 ammoniä solution (0.02 mol/1). For further Chromatographie Separation 10 of the dissolved residue are put on ITLC-SG plates. The plate is chiom&o-graphed in solvent A (front up to 20 cm), then dried 10 min at 100 °C. For the second dimension chromatography is done pver a 10 cm distance with solvent C (approx. 10 min) and then dried again. For detection the plate is sprayed with bromphenol blue. The «Nracetylglutamate spots (Rf: 0.3/0.05) are cut put and placed in a counting vial. 5 ml ammoniä (0.02 mol/1) are added, the vial shaken for 10 min and' then 7 ml aquaspl-ä js added particularly of N-acetylglutamate, the product of the enzyme reaction.
Recovery of N-acetylglutamate
These experiments had to be done with radioactive N-acetylglutamate, since this final reaction product becomes labeled during its synthesis by N-acetylglutamate synthetase. For this purpose [
14 C]-N-acetylglutarnate was synthesized from [ 14 C]-L-glutamate according to a modification of the method ofNoyori (12) .
Results
Separation of Substrates and products Column chromatography on Extrelut
We tried to separate Z-glutamate, N-acetylglutamate and /,-pyroglutamate (arising from glutamate) on Extrelut 0.5 ml of a solution containing l mg each of L-gJutamate, N-acetylglutamate and L-pyroglutamate was mixed with 0.5 rnl HC1 (l mol/1). The mixture was put on the Extrelut® column (0.55 g Extrelut®, column 20 cm X l cm ^). The column was eluted with 20 ml of solvent B. The eluate was collected äs a whole or in 5 ml fractions which were theri pooled. The whole eluate and the fractions were dried at 50 °C under nitrogen and the residüe taken up in l ml ammonia (0.02 mol/1). 10 of these Solutions were put on a cellulose thin layer plate (Merck). N-acetylglutamate andL-pyroglutamate are eluted tögether cornpletely. Glutamate however is retained. Examination of the different eluted fractions did not reveal any ehänges in Separation compared to the batqh elution.
Thin layer chromatography
If enzyme analysis is performed on tissue samples, interfering metabolites are to be expected. These must be separated from the Substrate and product of the reaction. Particularly metabolites from the Krebs cycle which may interfere are not separated by the Extrelut® step. Therefore a thiri layer chromatography step was added. After trying several Systems, a fully satisfactpry method was found 1 using a 2-dimensional chrprnatography on ITLC-SG^-ready plates (using solvente A and C äs indicated). Bromphenol blue was used for the detection. (D* On the bäsis of these findings it was possible to combine the Extrelut^ step with a thin layer chrorhatography step. However, it was necessary to assess the reeovery of the substances separated in these two Steps, and N-acetylglutamate (l g/l) was prepared. l ml of this solution was put on 10 different Extrelut® columns and eluted äs described above. The evaporated eluate was dissolved in ammonia (0.02 mol/1). 50 were put in aquasol-2 and the radioaetivity counted. A further 20 of eluate were put on 10 different Extrelut columns and eluted äs described above. The evaporated eluate was dissolved in ammonia (0.02 mol/1). 50 were put in aquasol-2 and the radioactivity counted. A further 20 of eluate were put on the ITLC-SG-ready plates and chromatographed äs described above. The N-acetylglutamate spot was cut out and counted. The recovery after the Extrelut" step alone and after Extrelut® elution and ITLC-SG-chromatography was calculated in relation to the amount of [ The recovery for the Extrelut® step was 99.8% (CV 0.5%, n = 10). For the Extrelut® System with the succeeding Chromatographie step the recovery was 97.8% (CV 1.3%, n = 10). These very high recoveries prove that the condition chosen for both Steps are correct. These recoveries are higher than those described by Shigesada & Tatibana in their System (13) .
Testing the enzyme assay by autoradiography
[
14 C]N-acetylglutamate synthesized during iiicubation with liver homogenate can also be demonstrated using autoradiographic techniques. After the 2-dimensional chromatography on ITLS-SG ready plates these were placed directiy on x-ray screen film (NS 2T, Kodak).. After three days exposure the films were develpped according to Swanstrom &Shank (14) . With this method activities up to 0.8 Bq/cm 2 can be detected. 
Further investigations of the enzyme reaction
Velocity and pH
The dependency of the velocity of the enzyme reaction on the amount of tissue used in the assay exhibited linearity up to a tissue content of 10 mg per assay. With respect to the incubation time the reaction is linear up to 20 minutes.
The dependency of the reaction on the pH is shown in figure 2 . With and without activation of the enzyme by arginine, the pH Optimum is around 8.5. The activation due to arginine approx. doubles the activity. Further kinetic data were obtained with a purified human N- Within-run precision: Using the same tissue sample the within-ruii precision showed a coefficjent of Variation of 8.7% at a mean activity of 30.7 mU/g tissue (n = 6). This is in oür opiniori acceptable in view of the complexity of the enzyme assay ;
Between däy precision: The precisipn from day to day shows a coefficient of Variation of 9.6% (tab. 1). The data further indicate that the störage of the liver homogenate at -20 °C during 5 days does not lead to a decrease of enzyme activity. 
Reference values
The amount of liver tissue (about 30 rng) necessäry for the assay of N-äcetylglutämäte synthetase usually cannot be obtained by a needle biopsy. Multiple needle biopsies embody the risk of haemorrhage; thus it is preferable to perform a surgical 'biopsy. TTiis becqmes a limiting factor for establishing reference values. Theref ore orily a smäll number öf liver specimens could be examined. Most of the control biopsies were taken from patients who were operated becraise of adenocarcinomä of the colon or rectum. Due to the limited number of assays, we could not account for sex differenees. The age of the patients varied between 48 arid 64 years. Preoperätively the patients had a standardized diet coiisistiiig of bouillon and tea for two days. A protein effect leading to an activation of N-acetylglutamate synthetase which is known for other enzymes of the urea cycle can be avoided with this diet (15) (16) (17) .
The determination of N-acetylglutamate S5m1hetase is merely used in the context öf diagnoses of hyperammonaemia in the newborn and infant age. It wasrhpwever not possible for ethical reasons to get reference samples in this age periöd. 
Discussion
The purpose of setting up a method for the determination of N-acetylglutamate synthetase in human liver biopsy specimens is mainly airned at the diagnosis of congenital hyperammonaemias (1) (2) (3) .
N-acetylglutamate generated in the N-acetylglutamate synthetase reaction (18, 19) holds a key position in regulation of urea synthesis. As shown recently, the deficiency of N-acetylglutamate synthetase rnay have been the cause of hyperammonaemia of unknown origin in newborn and small infants (10).
The methods for the determination of most urea cycle enzymes are not easy to perform. This is also the case for N-acetylglutamate synthetase.
The method described uses [ 14 C-U]labeled ghitamate ahd acetyl CoA äs Substrates. The Substrate concentrations used are based oii kinetic studies with the purified human enzyme (9) . It is composed of three Steps: the iricubation step and two Separation Steps. After incuba* tion the reaction product N-acetylglutamate is separated from the Substrate L-glutamate by chromatography on Extrelut® instead of Dowex 50-X8, äs proposed by Shigesada & Tatibana (8) . Many side reactions are to be expected in crude liver biopsy homogenates. Therefore a newly introduced thin layer chromatography step is used to separate the reaction product from the labeled metabolites, particularly from the Krebs cycle intermediates. Although some of these could be avoided by using glutamate labeled in position l, this compound is only available äs the J9.Z,-racemate and with a considerably lower specific activity.
Working with sonicated liver homogenates the activity of aminoacylase (EC 3.5.1.14) could be a disturbing factor, leading t o the breakdown of N-acetylglutamate. According to Reglero et al. (20) there is practically no activity of this enzyme in the mitochondria, whereas it is easily measurable in the cytosol (21) . However aminoacylase exhibits its pH Optimum at pH 7 (22) . At pH 8.5 used in the N-acetylglutamate synthetase reaction the activity of the aminoacylase is approxirnately half the maximal rate (23) . The final concentration of N-acetylglutarnate in the assay described is below 0.1 mmol/1, whereas the K m value of aminoacylase for N-acetylglutamate is about 10 mmol/1 (20) . On the basis of these observations we think that the interference of aminoacylase, if present at all, is certainly minimal. The method has a good within-run and between day precision äs well äs a good recovery. The enzyme activity is linear with time and protein content over a . large ränge. Its usefullness has been proven in the diagnosis of the first case of N-acetylglutamate synthetase deficiency (10)-,
